Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D and Levothyroxine for Lipids in Hypothyroidism
NCT06276205Phase 3Completed
- Sponsor
- King Edward Medical University
- Start
- Mar 2024
- Primary completion
- Jan 2025
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of vitamin d in dyslipidemia, sponsored by King Edward Medical University. Started Mar 2024; status: completed.
02
Drugs
vitamin d
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT06276205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06276205.